Tech Company Financing Transactions
Rgenta Therapeutics Funding Round
On 4/6/2020, Rgenta Therapeutics landed $20 million in Seed funding from Boehringer Ingelheim Venture Fund, Matrix Partners and Kaitai Capital.
Transaction Overview
Boehringer Ingelheim Venture Fund (Lead Investor) (Martin Heidecker)
Matrix Partners (Lead Investor)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 4/4/2020: OctoML venture capital transaction
Next: 4/6/2020: Tailscale venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs